BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 333796)

  • 1. [New viewpoints on the therapy and prevention of renal osteopathy].
    Kaiser W; Mampel E
    Z Gesamte Inn Med; 1977 Jun; 32(12):254-9. PubMed ID: 333796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of dihydrotachysterol in the treatment and prevention of uremic osteopathy in children].
    Sieniawska M; Białasik D
    Pediatr Pol; 1981 Jul; 56(7):733-41. PubMed ID: 7301469
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of bone disease with dihydrotachysterol in patients undergoing long-term hemodialysis.
    Cordy PE
    Can Med Assoc J; 1977 Oct; 117(7):766-8. PubMed ID: 907948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of renal osteodystrophy with dihydrotachysterol in non-dialyzed patients.
    Teredesai P; Winaver J; Martin LG; Cranley R; Conner TB; Hartsock RJ; Puschett JB
    Clin Nephrol; 1980 Jan; 13(1):31-9. PubMed ID: 7363513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydrotachysterol treatment in renal osteodystrophy; the effect on alkaline and acid phosphatase.
    Van Kesteren RG; Duursma SA; Dorhout Mees EJ
    Neth J Med; 1978; 21(1):17-22. PubMed ID: 634412
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of renal osteodystrophy].
    Duursma SA; Dorhout Mees EJ
    Ned Tijdschr Geneeskd; 1978 Mar; 122(11):373-8. PubMed ID: 634388
    [No Abstract]   [Full Text] [Related]  

  • 9. History and organization of the Growth Failure in Children with Renal Diseases Study.
    Chan JC; McEnery PT; Brouhard BH; Chinchilli VM; Greifer I
    J Pediatr; 1990 Feb; 116(2):S3-7. PubMed ID: 2405133
    [No Abstract]   [Full Text] [Related]  

  • 10. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention and therapy of regulatory hyperparathyroidism in kidney patients].
    Koall W; Mampel E; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Apr; 37(7):197-201. PubMed ID: 7048771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of ultra-filtrable serum calcium in parathyroid insufficiency following dihydrotachysterol administration. Animal experimental studies of a clinical phenomenon].
    Ponsold W; Pfordte K
    Dtsch Gesundheitsw; 1969 Mar; 24(8):376-8. PubMed ID: 5376408
    [No Abstract]   [Full Text] [Related]  

  • 13. [Renal osteopathy and bone mineralisation in patients treated with dihydrotachysterol during long term dialysis (author's transl)].
    Pogglitsch H; Schmidberger H; Gell G
    MMW Munch Med Wochenschr; 1976 Jan; 118(5):131-6. PubMed ID: 814443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of dihydrotachysterol on bone tissue in rats with experimental kidney failure].
    Iagodovskiĭ VS; Ermolenko VM; Spirichev VB; Blazheevich NV; Migunova NA
    Biull Eksp Biol Med; 1980 Nov; 90(11):611-3. PubMed ID: 7448398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dihydrotachysterol treatment in children with chronic renal failure].
    Sieniawska M; Tolloczko I
    Pol Tyg Lek; 1977 Jan; 32(5):181-4. PubMed ID: 834657
    [No Abstract]   [Full Text] [Related]  

  • 16. 1,25(OH)2D levels in dihydrotachysterol-treated patients: influence on 1,25(OH)2D assays.
    Taylor A; Norman ME
    J Bone Miner Res; 1987 Dec; 2(6):567-70. PubMed ID: 2844067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocalcemic hypercalciuria during vitamin D and dihydrotachysterol therapy of hypoparathyroidism.
    LITVAK J; MOLDAWER MP; FORBES AP; HENNEMAN PH
    J Clin Endocrinol Metab; 1958 Mar; 18(3):246-52. PubMed ID: 13513723
    [No Abstract]   [Full Text] [Related]  

  • 18. Questions on the use of vitamin D3.
    Balsan S; Steendijk R
    Pediatrics; 1980 Sep; 66(3):483-4. PubMed ID: 7422447
    [No Abstract]   [Full Text] [Related]  

  • 19. Parathyroid function in uremic children with and without osteodystrophy.
    Roof BS; Piel CF; Rames L; Potter D; Gordan GS
    Pediatrics; 1974 Mar; 53(3):404-9. PubMed ID: 4815261
    [No Abstract]   [Full Text] [Related]  

  • 20. Parathyroid suppressibility in renal osteodystrophy.
    Moorhead JF; Varghese Z; Tatler GL; Baillod RA; Ku G; Sweatman AJ; Wills MR
    Proc Eur Dial Transplant Assoc; 1975; 11():465-72. PubMed ID: 1197271
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.